Finzati - Logo
OSCR logo

Oscar Health, Inc.

OSCR • Medical - Healthcare Plans
$32.25
▲ +0.01 (+0.03%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$6.86B
Growth
15.4%
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive revenue growth · 42.8%Positive free cash flow · 4.03Manageable debt level · 0.44Weak liquidity · 0.95Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:58 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$32.25
Change0.03%
Market Cap$6.86B
52W Range10.69 - 33.10
Beta2.34
Gross Margin14.38%
Oper. Margin-3.39%
Profit Margin-3.79%
Debt/Eq0.44
Current Ratio0.95
Quick Ratio0.95
Revenue 5Y15.36%

Investment DNA

How strong this company looks for long-term investors

63
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
52/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Positive revenue growth · 42.8%Positive free cash flow · 4.03Manageable debt level · 0.44Weak liquidity · 0.95Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$16.00
Mean
$26.83
Median
$25.00
High
$39.00

Company Overview

IPO: 3/3/2021
Industry: Medical - Healthcare Plans
P/B i: 3.86
Debt / Equity i: 0.44
Operating Margin: -3.39%
Net Margin: -3.79%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: 0.44
Current Ratio: 0.95
Quick Ratio: 0.95
Status: Moderate

Warnings

  • Weak Liquidity

Insider Transactions

Recent executive and insider activity

⚠ 3 high-volume insider sells detected
Plouffe David
Transaction: 07/09/2026
BUY
Change
+681
Price
Not reported
Filing
07/13/2026
Type
BUY
Sankaran Sid
Transaction: 07/09/2026
BUY
Change
+858
Price
Not reported
Filing
07/13/2026
Type
BUY
Gassen William
Transaction: 07/09/2026
BUY
Change
+684
Price
Not reported
Filing
07/13/2026
Type
BUY